X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (94) 94
humans (90) 90
female (64) 64
oncology (55) 55
male (49) 49
middle aged (46) 46
adult (42) 42
aged (39) 39
animals (25) 25
abridged index medicus (23) 23
article (21) 21
mice (21) 21
cancer (20) 20
cell line, tumor (15) 15
hematology (15) 15
expression (14) 14
breast cancer (13) 13
chemotherapy (13) 13
research (13) 13
adolescent (12) 12
analysis (12) 12
angiogenesis (12) 12
breast neoplasms - pathology (12) 12
care and treatment (12) 12
flow cytometry (12) 12
immunology (12) 12
treatment outcome (12) 12
aged, 80 and over (11) 11
antineoplastic agents - therapeutic use (11) 11
metastasis (11) 11
mutation (11) 11
tumors (11) 11
antineoplastic agents - pharmacology (9) 9
follow-up studies (9) 9
risk (9) 9
xenograft model antitumor assays (9) 9
analysis of variance (8) 8
brain neoplasms - secondary (8) 8
breast neoplasms - drug therapy (8) 8
mice, nude (8) 8
prognosis (8) 8
survival (8) 8
brain neoplasms - prevention & control (7) 7
carcinoma (7) 7
cell proliferation - drug effects (7) 7
immunohistochemistry (7) 7
in-vitro (7) 7
mice, inbred balb c (7) 7
oncology, experimental (7) 7
pathology (7) 7
phase-ii (7) 7
survival rate (7) 7
therapy (7) 7
breast neoplasms - metabolism (6) 6
cells, cultured (6) 6
child (6) 6
combined modality therapy (6) 6
diagnosis (6) 6
gene expression (6) 6
genetic aspects (6) 6
health aspects (6) 6
immunophenotyping (6) 6
immunotherapy (6) 6
in-vivo (6) 6
melanoma (6) 6
pediatrics (6) 6
prospective studies (6) 6
prostate cancer (6) 6
retrospective studies (6) 6
t cells (6) 6
antibodies, monoclonal - therapeutic use (5) 5
antibodies, monoclonal, humanized (5) 5
antigens (5) 5
apoptosis (5) 5
brain metastasis (5) 5
cells (5) 5
dendritic cells (5) 5
drug therapy (5) 5
endothelial growth-factor (5) 5
gene expression regulation, neoplastic (5) 5
genotype (5) 5
growth (5) 5
inhibition (5) 5
kaplan-meier estimate (5) 5
lymphocytes (5) 5
minimal residual disease (5) 5
molecular sequence data (5) 5
peripheral-blood (5) 5
phase-ii trial (5) 5
progression (5) 5
prostatic neoplasms - pathology (5) 5
risk factors (5) 5
statistics, nonparametric (5) 5
surgery (5) 5
survival analysis (5) 5
time factors (5) 5
young adult (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
antitumor-activity (4) 4
bevacizumab (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuro-Oncology, ISSN 1522-8517, 11/2018, Volume 20, Issue 12, pp. 1643 - 1651
Abstract Background Plexiform neurofibromas (PN) in neurofibromatosis 1 (NF1) can cause substantial morbidities. Clinical trials targeting PN have recently... 
neurofibromatosis type 1 | morbidity | function | plexiform neurofibroma | YOUNG-ADULTS | TRIALS | ONCOLOGY | MRI | TYPE-1 | CLINICAL NEUROLOGY | CHILDREN
Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 03/2017, Volume 64, Issue 3, p. e26273
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 1794 - 1794
Background: Liver metabolism plays a major role in life-long exposure to endogenous and exogenous carcinogens. We therefore explored associations between... 
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 8/2008, Volume 100, Issue 15, pp. 1092 - 1103
Journal Article
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2016, Volume 159, Issue 1, pp. 311 - 319
Journal Article
Journal Article
Translational lung cancer research, ISSN 2218-6751, 06/2019, Volume 8, Issue 3, p. 247
Single-agent pemetrexed is a treatment for recurrent non-squamous non-small cell lung cancer (NSCLC) that provides limited benefit. Preclinical studies showed... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2003, Volume 21, Issue 16, pp. 3127 - 3132
Purpose : This three-arm randomized study compares response rates and overall survival of patients with metastatic renal cell cancer (RCC) receiving high-dose... 
TRIAL | INTERFERON | MELANOMA | SUBCUTANEOUS INTERLEUKIN-2 | ONCOLOGY | HOME-THERAPY | PHASE-II | RECOMBINANT INTERLEUKIN-2 | CELL CARCINOMA | Prognosis | Interleukin-2 - administration & dosage | Humans | Middle Aged | Survival Analysis | Female | Kidney Neoplasms - pathology | Male | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy | Index Medicus
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 4/2014, Volume 63, Issue 4, pp. 407 - 418
We recently reported the clinical results of a Phase I trial combining ipilimumab with a vaccine containing transgenes for prostate-specific antigen (PSA) and... 
NK cells | Immunology | Medicine & Public Health | Ipilimumab | Immunotherapy | Oncology | Cancer Research | Vaccine | T cells | PROSTVAC | SURVIVAL | CTLA-4 BLOCKADE | ANTI-CTLA-4 THERAPY | DOSE-ESCALATION TRIAL | RADICAL PROSTATECTOMY | MELANOMA PATIENTS | IMMUNOLOGY | ANTITUMOR-ACTIVITY | TUMOR-INFILTRATING LYMPHOCYTES | ONCOLOGY | REGULATORY T-CELLS | SUPPRESSOR-CELLS | T-Lymphocyte Subsets - immunology | Humans | Antibodies, Monoclonal - therapeutic use | Male | Membrane Proteins - analysis | T-Lymphocytes, Regulatory - immunology | Cancer Vaccines - therapeutic use | Flow Cytometry | Killer Cells, Natural - immunology | Prostatic Neoplasms, Castration-Resistant - therapy | T-Lymphocytes, Regulatory - chemistry | Antigens, Differentiation - analysis | Prostatic Neoplasms, Castration-Resistant - blood | Adenocarcinoma - blood | Cancer Vaccines - administration & dosage | Kaplan-Meier Estimate | Immunophenotyping | Vaccines, Synthetic - therapeutic use | Combined Modality Therapy | Prostatic Neoplasms, Castration-Resistant - drug therapy | Adenocarcinoma - drug therapy | Hepatitis A Virus Cellular Receptor 2 | Adenocarcinoma - secondary | Prostate-Specific Antigen - blood | Adenocarcinoma - therapy | Antibodies, Monoclonal - administration & dosage | Lymphocyte Count | Th17 Cells - immunology | Vaccines, Synthetic - administration & dosage | Killer Cells, Natural - chemistry | Cancer patients | Care and treatment | Chemotherapy | Clinical trials | Metastasis | Vaccines | Prostate cancer | Cells | Cancer | Index Medicus | vaccine | ipilimumab | immunotherapy
Journal Article